CLINICAL HISTORY: r/o COVID19 by SARS CoV-2 RNA (COVID 19) QUALTATIVE NAAT
Comment: APTIMA SARS CoV-2 assay combine with technologies of target capture TMA/DKA. Positive result indicate the presence of COVID viral RNA, but the clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Negative results should be considered in the context of a patient's recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19. This test has been authorized by FDA under an Emergency Use Authorization (EUA A nasopharyngeal specimen is the preferred choice for swab-based SARS-CoV-2 testing.
CPT CODES: U0003, 99212, 99202 ICD-9 CODES: Z20.828
Please click one of the PayPal options to complete payment and submit the form.